Access cutting-edge ulcerative colitis treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access ulcerative colitis specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ulcerative colitis treatment provided free
Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess how safe and effective Upadacitinib is in treating pediatric participants with UC. Adverse events and change in disease activity will be assessed. Upadacitinib (RINVOQ) is a drug approved in adults for moderate- to severely active UC and is being developed for moderate- to severely active UC in pediatric participa
Sponsor: AbbVie
Check if you qualify for this ulcerative colitis clinical trial in Palo Alto, CA
If you're searching for ulcerative colitis treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ulcerative colitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.